Clinical trials
Active, not recruiting Neurodegenerative Diseases trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 1 |
| Eli Lilly and Company | 1 |
| H. Lundbeck A/S | 1 |
| Novartis Pharmaceuticals | 1 |
| Vertex Pharmaceuticals Incorporated | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neurodegenerative Diseases | 5 |
| Alzheimer Disease | 2 |
| Brain Diseases | 2 |
| Dementia | 2 |
| Nervous System Diseases | 2 |
| Central Nervous System Diseases | 1 |
| Cognitive Dysfunction | 1 |
| Genetic Diseases, Inborn | 1 |
| Heredodegenerative Disorders, Nervous System | 1 |
| Huntington Disease | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.